Evidence map›Paper›PMID 27550733›Full record

ArticleNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2017

Impact of Maternal Serotonin Transporter Genotype on Placental Serotonin, Fetal Forebrain Serotonin, and Neurodevelopment.

Christopher L Muller, Allison Mj Anacker, Tiffany D Rogers, Nick Goeden, Elizabeth H Keller, C Gunnar Forsberg, Travis M Kerr, Carly LA Wender, George M Anderson, Gregg D Stanwood and 3 more

Abstract read
In one paragraph

Article in Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Tryptophan's Journey Through Pregnancy: The Role of Serotonin.International journal of tryptophan research : IJTR · 2026
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Contribution of the serotonergic system to developmental brain abnormalities in autism spectrum disorder.Autism research : official journal of the International Society for Autism Research · 2024
    Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Christopher L MullerGraduate Program in Neuroscience, Vanderbilt University, Nashville, TN, USA.
Allison Mj AnackerDepartment of Psychiatry, Columbia University Medical School, New York, NY, USA.
Tiffany D RogersDepartment of Psychiatry, Vanderbilt University School of Medicine, Nashville, TN, USA.
Nick GoedenDepartment of Cell and Neurobiology and Zilkha Neurogenetic Institute, University of Southern California School of Medicine, Los Angeles, CA, USA.
Elizabeth H KellerDepartment of Psychiatry, Vanderbilt University School of Medicine, Nashville, TN, USA.
C Gunnar ForsbergDepartment of Psychiatry, Vanderbilt University School of Medicine, Nashville, TN, USA.
Travis M KerrDepartment of Psychiatry, Vanderbilt University School of Medicine, Nashville, TN, USA.
Carly LA WenderDepartment of Psychiatry, Columbia University Medical School, New York, NY, USA.
George M AndersonChild Study Center, Yale University School of Medicine, New Haven, CT, USA.
Gregg D StanwoodDepartment of Biomedical Sciences, Florida State University, Tallahassee, FL, USA.
Randy D BlakelyDepartment of Psychiatry, Vanderbilt University School of Medicine, Nashville, TN, USA.
Alexandre BonninDepartment of Cell and Neurobiology and Zilkha Neurogenetic Institute, University of Southern California School of Medicine, Los Angeles, CA, USA.
Jeremy Veenstra-VanderWeeleDepartment of Psychiatry, Columbia University Medical School, New York, NY, USA.

Funding

THREE-TIERED PREVENTION MODEL TO BETTER SERVE ALL STUDENP30HD015052 · NICHD · VANDERBILT UNIVERSITY · PI DYKENS, ELISABETH MAY · 1985 to 2014
$18.6M
Translational Research Training in Child PsychiatryT32MH016434 · NIMH · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI Cristiane S. Duarte, Kate Dimond Fitzgerald · 1985 to 2026
$10.9M
Research Project: Sensory and Multisensory Contributions to AutismU54HD083211 · NICHD · VANDERBILT UNIVERSITY MEDICAL CENTER · PI DYKENS, ELISABETH MAY · 2015 to 2019
$7.1M
Program in NeurogenomicsT32MH065215 · NIMH · VANDERBILT UNIVERSITY · PI ROGER J COLBRAN · 2002 to 2026
$6.4M
Prenatal stress and antidepressants effects on offspring brain developmentR01MH106806 · NIMH · UNIVERSITY OF SOUTHERN CALIFORNIA · PI BONNIN, ALEXANDRE · 2016 to 2020
$2.1M
Neurobiological Signatures of Social Dysfunction and Repetitive BehaviorR01MH094604 · NIMH · VANDERBILT UNIVERSITY · PI VEENSTRA-VANDERWEELE, JEREMY · 2011 to 2015
$2.0M
NICHD NIH HHS P30 HD015052NICHD NIH HHS U54 HD083211NIMH NIH HHS R01 MH094604NIMH NIH HHS R01 MH106806NIMH NIH HHS T32 MH016434NIMH NIH HHS T32 MH065215
6 · The paper itself

Abstract

Biomarker, neuroimaging, and genetic findings implicate the serotonin transporter (SERT) in autism spectrum disorder (ASD). Previously, we found that adult male mice expressing the autism-associated SERT Ala56 variant have altered central serotonin (5-HT) system function, as well as elevated peripheral blood 5-HT levels. Early in gestation, before midbrain 5-HT projections have reached the cortex, peripheral sources supply 5-HT to the forebrain, suggesting that altered maternal or placenta 5-HT system function could impact the developing embryo. We therefore used different combinations of maternal and embryo SERT Ala56 genotypes to examine effects on blood, placenta and embryo serotonin levels and neurodevelopment at embryonic day E14.5, when peripheral sources of 5-HT predominate, and E18.5, when midbrain 5-HT projections have reached the forebrain. Maternal SERT Ala56 genotype was associated with decreased placenta and embryonic forebrain 5-HT levels at E14.5. Low 5-HT in the placenta persisted, but forebrain levels normalized by E18.5. Maternal SERT Ala56 genotype effects on forebrain 5-HT levels were accompanied by a broadening of 5-HT-sensitive thalamocortical axon projections. In contrast, no effect of embryo genotype was seen in concepti from heterozygous dams. Blood 5-HT levels were dynamic across pregnancy and were increased in SERT Ala56 dams at E14.5. Placenta RNA sequencing data at E14.5 indicated substantial impact of maternal SERT Ala56 genotype, with alterations in immune and metabolic-related pathways. Collectively, these findings indicate that maternal SERT function impacts offspring placental 5-HT levels, forebrain 5-HT levels, and neurodevelopment.

Indexed as

Maternal-Fetal ExchangeAnimalsFemaleGenotypeMice, Inbred StrainsMice, TransgenicPlacentaPregnancyProsencephalonRhombencephalonSerotoninSerotonin Plasma Membrane Transport ProteinsThalamusSerotoninSerotonin Plasma Membrane Transport ProteinsSlc6a4 protein, mouse

Identifiers

PMID27550733
PMCPMC5399236

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.